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Despite advances in diagnosis, surgery, and antimicrobial therapy, mortality rates associated with complicated
intra-abdominal infections remain exceedingly high. The World Society of Emergency Surgery (WSES) has designed
the CIAOW study in order to describe the clinical, microbiological, and management-related profiles of both
community- and healthcare-acquired complicated intra-abdominal infections in a worldwide context. The CIAOW
study (Complicated Intra-Abdominal infection Observational Worldwide Study) is a multicenter observational study
currently underway in 57 medical institutions worldwide. The study includes patients undergoing surgery or
interventional drainage to address complicated intra-abdominal infections. This preliminary report includes all data
from almost the first two months of the six-month study period. Patients who met inclusion criteria with either
community-acquired or healthcare-associated complicated intra-abdominal infections (IAIs) were included in the
study. 702 patients with a mean age of 49.2 years (range 18–98) were enrolled in the study. 272 patients (38.7%)
were women and 430 (62.3%) were men. Among these patients, 615 (87.6%) were affected by community-acquired
IAIs while the remaining 87 (12.4%) suffered from healthcare-associated infections. Generalized peritonitis was
observed in 304 patients (43.3%), whereas localized peritonitis or abscesses was registered in 398 (57.7%) patients.
The overall mortality rate was 10.1% (71/702). The final results of the CIAOW Study will be published following the
conclusion of the study period in March 2013.* Correspondence: m.sartelli@virgilio.it
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Intra-abdominal infections (IAIs) include a wide spectrum
of pathological conditions, ranging from uncomplicated
appendicitis to fecal peritonitis [1].
From a clinical perspective, IAIs are classified in two
major categories: complicated and uncomplicated.
In uncomplicated IAIs, the infectious process only
involves a single organ and does not spread to the periton-
eum. Patients with such infections can be managed with
either surgical resection or antibiotics. When the focus of
infection is treated effectively by surgical excision, 24-hour
perioperative prophylaxis is typically sufficient. Patients
with less severe intra-abdominal infections, including
acute diverticulitis and certain forms of acute appendicitis,
may be treated non-operatively.
In complicated IAIs, the infectious process extends be-
yond a singularly affected organ, and causes either loca-
lized peritonitis or diffuse peritonitis. The treatment of
patients with complicated intra-abdominal infections
involves both source control and antibiotic therapy.
Intra-abdominal infections are further classified in two
groups: community-acquired intra-abdominal infections
(CA-IAIs) and healthcare-associated intra-abdominal
infections (HA-IAIs). CA-IAIs are acquired directly in the
community while HA-IAIs develop in hospitalized patients
or residents of long-term healthcare facilities. HA-IAIs are
associated with higher rates of mortality due to the
patients’ poorer underlying health and an increased likeli-
hood of infection by multi-drug resistant microorganisms.
Source control encompasses all measures undertaken
to eliminate the source of infection and to control on-
going contamination.
The most common source of infection in community-
acquired intra-abdominal infections is the appendix, fol-
lowed by the colon, and then the stomach. Dehiscence
complicates 5-10% of intra-abdominal bowel anastomoses
and is associated with high rates of mortality [2].
Ultrasound- and CT-guided percutaneous drainage of
abdominal and extra-peritoneal abscesses have proven to
be safe and effective in select patients [3-10].
Surgery is the most important therapeutic recourse for
controlling intra-abdominal infections.
Generally, the choice of the procedure depends on the
anatomical source of infection, on the degree of periton-
eal inflammation, on the generalized septic response and
on the patient’s general conditions.
Patients suffering from severe peritonitis are prone to
persisting intra-abdominal sepsis, even when the source of
infection has been neutralized. Timely re-laparotomy is
the only possible known surgical recourse, capable to sig-
nificantly improve patient outcome in these cases.
In the event of secondary peritonitis, the decision and
timing of re-laparotomy is largely subjective and is often
based on a surgeon’s professional experience. Factorsindicative of progressive or persistent organ failure during
early postoperative follow-up analysis are the strongest
indicators of ongoing infection and suggest positive find-
ings upon re-laparotomy [11-13].
Three methods of localized, mechanical management of
abdominal sepsis following the initial laparotomy, which
was performed for purposes of source control, are currently
debated within the medical community: open-abdomen,
planned re-laparotomy and on-demand re-laparotomy
Antimicrobial therapy plays an integral role in the
management of intra-abdominal infections, especially in
critically ill patients requiring immediate empiric anti-
biotic therapy.
Empiric antibiotic therapy accounts for the most fre-
quently isolated microorganisms as well as any local
trends of antibiotic resistance.
The major pathogens involved in community-acquired
intra-abdominal infections are Enterobacteriaceae and
anaerobic microbes (especially B. fragilis).
An antimicrobial-based approach to treating intra-
abdominal infections involves a delicate balance between
the optimization of empirical therapy, which has been
shown to improve clinical outcomes, and the reduction of
excessive antimicrobial use, which has been proven to in-
crease the rate of emergence of antimicrobial-resistant
strains.
The threat of antimicrobial resistance is one of the
major challenges associated with the antimicrobial man-
agement of complicated intra-abdominal infections.
The recent and rapid spread of serine carbapenemases
in Klebsiella pneumoniae (KPC) has become an import-
ant concern when administering antimicrobial therapy
in hospitals worldwide [14].
The growing emergence of multidrug-resistant bac-
teria and the limited availability of new antibiotics to
counteract them has brought about an impending crisis
with alarming implications (especially regarding gram-
negative microorganisms).Methods
Aim
The purpose of the study is to describe the clini-
cal, microbiological, and treatment profiles of both
community-associated and healthcare-acquired com-
plicated intra-abdominal infections (IAIs) in a world-
wide context.
Patients older than 18 years with both community-
acquired and healthcare-associated intra-abdominal infec-
tions will be included in the database.
In Europe, the CIAO Study has recently ended, conclud-
ing a six-month, multicenter observational study across
twenty European countries. The study’s findings have re-
cently been published [15].
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World Society of Emergency Surgery (WSES) has
designed a prospective observational study investigating
the management of complicated intra-abdominal infec-
tions in a worldwide context.
Study population
The CIAOW study (Complicated Intra-Abdominal in-
fection Observational Worldwide Study) is a multicenter
observational study currently underway in 57 medical
institutions worldwide. The study includes patients
undergoing surgery or interventional drainage to address
complicated IAIs.
Medical institutions from each continent participate in
the study. The geographical distribution of the partici-
pating centers is represented in Figure 1.
Study design
The study does not attempt to change or modify the la-
boratory or clinical practices of the participating physi-
cians, and neither informed consent nor formal approval
by an Ethics Committee has been required.
The study meets the standards outlined in the Declar-
ation of Helsinki and Good Epidemiological Practices.
The study is monitored by the coordination center,
which investigates and verifies missing or unclear data
submitted to the central database. It is performed under
the direct supervision of the board of directors of WSES.
Data collection
In each center, the coordinator collects and compiles data
in an online case report system.These data include the
following: (i) patient and disease characteristics, i.e., demo-
graphic data, type of infection (community- or healthcare-
acquired), severity criteria, previous curative antibiotic
therapy administered in the 7 days preceding surgery;
(ii) origin of infection and surgical procedures performed;
and (iii) microbiological data, i.e., identification of bacteria
and microbial pathogens within the peritoneal fluid, the
presence of yeasts (if applicable), and the antibiotic sus-
ceptibilities of bacterial isolates.
The primary endpoints include the following:
 Clinical profiles of intra-abdominal infections
 Epidemiological profiles (epidemiology of the
microorganisms isolated from intra-abdominal
samples and these organisms’ resistance to
antibiotics)
 Management profiles
Statistical analysis
At the end of the six-month study period statistical com-
parisons will be performed using the Student’s t-test, χ2
analysis, or the Kruskall–Wallis/Wilcoxon tests, asdictated by the natural parameters of the data. Statistical
significance will be defined as a P-value less than 0.05
(P < 0.05). Multivariate analysis will be carried out by
means of stepwise logistic regressions in order to assess
the predictive factors of mortality during hospitalization.
Adjusted odds ratios (OR) and their 95% confidence
intervals (CI) will also be included.
Inclusion criteria
 Patients older than 18 years
 Community- and healthcare-acquired complicated
intra-abdominal infections
Exclusion criteria
 Age under 18 years old
 Pancreatitis
 Primary peritonitis.
Preliminary results
Patients
This preliminary report includes all data from the first
two months of the six-month study period.
702 patients with a mean age of 49.2 years (range 18–
98) were enrolled in the study. 272 patients (38.7%) were
women and 430 (62.3%) were men. Among these patients,
615 (87.6%) were affected by community-acquired IAIs
while the remaining 87 (12.4%) suffered from healthcare-
associated infections.
304 patients (43.3%) were affected by generalized peri-
tonitis while 398 (57.7%) suffered from localized periton-
itis or abscesses.
112 patients (15.9%) were admitted in critical condi-
tion (severe sepsis, septic shock).
Source control
The various sources of infection are outlined in Table 1.
The most frequent source of infection was acute appen-
dicitis. 243 cases were attributable to this condition.
The most frequently performed procedure employed
to address complicated appendicitis was the open ap-
pendectomy. 136 patients (55.9%) admitted for compli-
cated appendicitis underwent open appendectomies: 95
patients (69.8%) for localized infection or abscesses and
41 patients (31.2%) for generalized peritonitis. A laparo-
scopic appendectomy was performed on 93 patients
(39.4%) presenting with complicated acute appendicitis,
82 (88.2%) and 11 (11.8%) of whom underwent the pro-
cedure for localized peritonitis/abscesses and generalized
peritonitis, respectively. Open colonic resection was per-
formed on 1 patient to address complicated appendicitis.
In the other cases of complicated appendicitis, conserva-
tive treatment (percutaneous drainage, surgical drainage,
Figure 1 Participating centers for each continent.
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patients underwent percutaneous drainage to address
appendicular abscesses.
For patients with complicated acute cholecystitis (104
cases), the most frequently performed procedure to address
cholecystitis was the open cholecystectomy. 53 cholecyst-
itis patients (51%) underwent this procedure. A laparo-
scopic cholecystectomy was performed on 27 patients
(26%). In the remaining cases, conservative treatment
methods (percutaneous drainage, non-operative treatment)
were alternatively employed.
Among the patients with complicated diverticulitis
(40) the Hartmann resection was the most frequently
performed procedure. 12 patients (30%) underwent a
Hartmann resection. All these resections were open pro-
cedures. 8 of these patients underwent a Hartmann re-
section for generalized peritonitis, while the remaining 4
underwent the same procedure for localized peritonitis
or abscesses.
Colo-rectal resection was performed in 11 cases
(27.5%) (4 with and 7 without stoma protection).
The other patients received conservative treatment (per-
cutaneous drainage, non-operative treatment, surgical
drainage and stoma). Only two (5%) underwent laparo-
scopic lavage and drainage.
Of the 100 patients with gastro-duodenal perforations,
the most frequent surgical procedure was gastro-duodenal
suture. It was performed in 91 patients (91%): 85 patients
underwent open gastro-duodenal suture and 6 patients
underwent laparoscopic gastro-duodenal suture. Four
(4%) patients underwent gastro-duodenal resection. Theremaining patients (5%) received conservative treatment
(non-operative treatment, surgical drainage).
Among the 53 patients with small bowel perforations,
35 underwent open small bowel resection (79.5%) and
one (4.5%) underwent laparoscopic small bowel resec-
tion. Fourteen patients were treated by stoma. Two
patients were treated by open drainage
Among the 38 patients with colonic non-diverticular
perforation, 15 patients (66%) underwent open Hartmann
resection, 1 patient (2.6%) underwent laparoscopic
Hartmann resection, 9 (25%) underwent open resection
with anastomosis and without stoma protection, and 4
underwent open resection with stoma protection (10.5%).Microbiology
Intraperitoneal specimens were collected from 415
(59.1%) patients.
Intraperitoneal specimens were isolated from 336 of
the 615 patients with community-acquired intra-abdom-
inal infections (54.6%). Among the remaining 87 patients
with healthcare-associated intra-abdominal infections,
intraperitoneal specimens were collected from 79
patients (90.9%).
The major pathogens involved in intra-abdominal
infections were found to be Enterobacteriaceae.
The aerobic bacteria identified in samples of peritoneal
fluid are reported in Table 2.
According to CIAOW Study data, ESBL producers
were the most commonly identified drug-resistant
microorganism involved in IAIs.
Table 1 Source of infection
Source of infection Patients
N 702 (100%)
Appendicitis 243 (34.6%)
Cholecystitis 104 (14.8%)
Post-operative 53 (7.5%)
Colonic non diverticular perforation 38 (5.4%)
Gastroduodenal perforations 100 (14.2%)
Diverticulitis 40 (5.7%)
Small bowel perforation 53 (7.5%)
Others 52 (7.4%)
PID 8 (1.1%)
Post traumatic perforation 11 (1.6%)
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resistant to Carbapenems.
Among the identified aerobic gram-negative isolates,
there were 25 isolates of Pseudomonas aeruginosa, com-
prising 5.5% of all identified aerobic bacteria isolates.
Among the identified aerobic gram-positive bacteria,
Enterococci (E. faecalis and E. faecium) were the most
prevalent, representing 10.5% of all aerobic isolates, 3
glycopeptide-resistant Enterococci were identified; 2 were
glycopeptide-resistant Enterococcus faecalis isolates and 1
was glycopeptide-resistant Enterococcus faecium isolates.
Tests for anaerobes were conducted for 168 patients.
52 anaerobes were observed. The most frequently iden-
tified anaerobic pathogen was Bacteroides. 39 Bacteroides
isolates were observed during the course of the study.Table 2 Aerobic bacteria identified in peritoneal fluid
Total
Aerobic gram-negative bacteria
Escherichia coli
(Escherichia coli resistant to third generation cephalosporins)
Klebsiella pneuumoniae
(Klebsiella pneumoniae resistant to third generation cephalosporins)
Klebsiella oxytoca
Enterobacter
Proteus
Pseudomonas
Others
Aerobic gram-positive bacteria
Enterococcus faecalis
Enterococcus faecium
Staphylococcus Aureus
Streptococcus spp.
OthersAdditionally, 36 Candida isolates were collectively
identified. 30 were Candida albicans and 6 were non-
albicans Candida.
Outcome
The overall mortality rate was 10.1% (71/702).
68 patients (9.7%) were admitted to the intensive care
unit in the early recovery phase immediately following
surgery.
90 patients (12.8%) ultimately required additional surger-
ies; 54% of these underwent relaparotomies “on-demand”,
28.9% underwent open abdomen procedures.
According to univariate statistical analysis, a critical
clinical condition (severe sepsis and septic shock) upon
hospital admission was the most significant risk factor
for death; indeed, the rate of patient mortality was 36.6%
(41/112) among critically ill patients (patients presenting
with septic shock and severe sepsis upon admission), but
the mortality rate was only 5.1% (30/590) for clinically
stable patients (p < 0.0001).
For patients with generalized peritonitis, the mortality
rate was 18% (55/304) while patients with localized peri-
tonitis or abscesses demonstrated a mortality rate of
only 4% (16/398) (p < 0,001).
The immediate post-operative clinical course was a
significant parameter for predicting mortality: the rate of
patient mortality was 54.9% (51/93) among critically ill
patients (patients presenting with septic shock and se-
vere sepsis upon the immediate post-operative course),
but the mortality rate was only 3.3% (20/609) for clinic-
ally stable patients (p < 0.0001).455 (100%)
352
226(49.7%)
37 (8.1%)
53 (11.6%)
13 (2.9%)
3 (0.7%)
10 (2.2%)
13 (2.9%)
25 (5.5%)
22 (4.8%)
103
27 (5.9%)
21 (4.6%)
11 (2.4%)
29 (6.5%)
15 (3.3%)
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MedCalcW statistical software.Conclusion
Complicated intra-abdominal infections remain an import-
ant cause of morbidity with poor clinical prognoses.
The purpose of the CIAOW Study is to describe the epi-
demiological, clinical, microbiological, and treatment pro-
files of both community-acquired and healthcare-acquired
complicated intra-abdominal infections (IAIs) based on the
data collected over a six-month period (October 2012 to
March 2013) from 56 medical institutions Worldwide.
The final results of the CIAOW Study will be pub-
lished following the conclusion of the study period in
March 2013.
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